Category: Latest News
-
Occidental Shares Rise Amid Talks to Sell OxyChem
Occidental Petroleum’s (NYSE:OXY) stock climbed over 1% in premarket trading after reports indicated that the company is in advanced negotiations to sell its chemical unit, OxyChem, for a figure of at least $10 billion. Barclays noted that the potential divestment “would accelerate balance sheet normalization and position the company to increase cash returns.” Sources suggest…
-
Enanta Shares Slide After RSV Candidate Falls Short in Phase 2b Trial
Enanta Pharmaceuticals (NASDAQ:ENTA) saw its shares drop 14% following news that its investigational RSV therapy, zelicapavir, did not achieve the primary endpoint in a Phase 2b study involving high-risk adult patients. The trial focused on the time it took for four key lower respiratory tract symptoms to improve to a mild level, which represented the…
-
Dow Jones, S&P, Nasdaq, Wall Street, Five Key Market Events to Track This Week
Investors are preparing for a week shaped by U.S. labor data and potential political risks. The release of the September nonfarm payrolls report is expected to dominate headlines, while attention will also turn to the possibility of a federal government shutdown. Economic indicators from the Institute for Supply Management (ISM) and earnings from major companies…
-
Dollar Weakens as Markets Eye U.S. Shutdown Risks and Jobs Data
The U.S. dollar edged lower on Monday amid investor caution over a potential federal government shutdown, alongside anticipation of key economic reports later this week. By 05:35 ET (09:35 GMT), the U.S. dollar index, which tracks the currency against a basket of major peers, had slipped 0.2% to 97.92. Attention is now focused on Friday’s…
-
Biotech Innovators Drive the Future of Next-Generation Therapeutics
The biotechnology sector is rapidly advancing, introducing next-generation drug delivery and precision therapeutics that aim to make treatments less invasive, more targeted, and easier for patients. Innovations such as dissolvable microneedles, oral biologics, DNA-based medicines, and advanced small molecules are moving from research to clinical application, with late-stage trials, regulatory filings, and new financings accelerating…
-
Comcast Contributes $40,000 to Boys & Girls Clubs of Fresno County to Boost Digital Learning Opportunities
Comcast (NASDAQ:CMCSA) has pledged $40,000 to the Boys & Girls Clubs of Fresno County (BGCFC) as of September 24. The donation will help fund after-school programs that focus on technology skills and digital learning for students. “At Comcast, we believe every student deserves access to tools and opportunities that will help them thrive in a…
-
Pet Care Market Set to Reach $368 Billion by 2030, Key Players Driving Growth
The pet care industry continues to surge as one of the fastest-growing consumer sectors worldwide. Global spending on pets reached $246 billion in 2023 and is projected to climb to $368 billion by 2030. In the United States alone, veterinary services accounted for $38 billion, while spending on pet food and products exceeded $147 billion.…
-
Octane11 Connects to LinkedIn Company Intelligence API, Enhancing B2B Marketing Insights
Octane11 has announced its integration with LinkedIn’s newly launched Company Intelligence API, offering B2B marketers enhanced attribution and analytics capabilities. In pre-release testing, Octane11 evaluated match rates, engagement statistics, and costs before and after access to the new API. The results showed that, on average, customers experienced a threefold increase in account visibility and a…
-
Stellantis Appoints Joao Laranjo as New CFO Following Ostermann’s Departure
Stellantis (NYSE:STLA) announced on Monday that Joao Laranjo has been named the company’s new Chief Financial Officer. Laranjo will take over from Doug Ostermann, who resigned from the role for personal reasons, the automaker said in a statement. Despite the leadership change, Stellantis confirmed it is maintaining its financial guidance for 2025. Laranjo brings extensive…
-
AstraZeneca to Adopt Direct U.S. Listing While Retaining London Base
AstraZeneca (NASDAQ:AZN) said on Monday it will transition to a direct listing on the New York Stock Exchange, replacing its current depositary receipt structure, in a move aimed at attracting a wider range of global investors. The company confirmed it will remain headquartered and listed in London. The announcement may ease concerns among UK investors…